Durham-based Avicenna raises $6 million for ALS drug research
The company previously raised $2.5 million in September 2020 and $3 million in December 2022, according to Crunchbase.
Read MoreAvicenna Biosciences
Durham biotech startup Avicenna Biosciences raises $2.5M
Stealthy startup Avicenna Biosciences has raised $2.5 million in equity, according to a recent securities filing.
Read More
